Brief: Kezar Receives FDA Clearance Of Zetomipzomib IND For Treatment Of Autoimmune Hepatitis
03/10/2022 21:03
Oct 3 (Reuters) - Kezar Life Sciences Inc KZR.O :
* KEZAR LIFE SCIENCES RECEIVES FDA CLEARANCE OF IND FOR
ZETOMIPZOMIB FOR THE TREATMENT OF AUTOIMMUNE HEPATITIS
Source text for Eikon: ID:nBw3cBH5Sa
Further company coverage: KZR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kezar Life Sciences
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. STOCKS ON THE MOVE-Sysco, Crowdstrike, GM